PA5-55533

antibody from Invitrogen Antibodies

Targeting: CDCA7L JPO2, R1, RAM2

Western blot (Data presented on provider website)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-55533

Provider

Invitrogen Antibodies

Product name

CDCA7L Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Recombinant protein fragment

Description

Immunogen sequence: VRFHSKYFTE ELRRIFIEDT DSETEDFAGF TQSDLNGKTN PEVMVVESDL SDDGKASLVS EEEEDEEEDK ATPRRSRSRR SSIGLRVAFQ FPTKKLANKP DKNSSSEQLF SSARLQNEKK TILERKKDCR QVIQREDSTS ESE Highest antigen sequence identity to the following orthologs: Mouse - 60%, Rat - 57%.

Reactivity

Human

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

0.2 mg/mL

Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Immunocytochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunofluorescent staining of CDCA7L in human cell line A-431 shows positivity in nucleus & nucleoli. Samples were probed using a CDCA7L Polyclonal Antibody (Product # PA5-55533).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunofluorescent staining of CDCA7L in human cell line A-431 using a CDCA7L Polyclonal Antibody (Product # PA5-55533) shows localization to nucleus and nucleoli.

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunofluorescent staining of CDCA7L in human cell line A-431 using a CDCA7L Polyclonal Antibody (Product # PA5-55533) shows localization to nucleus and nucleoli.

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical analysis of CDCA7L in human appendix using CDCA7L Polyclonal Antibody (Product # PA5-55533) shows strong nuclear positivity in lymphoid reaction center cells.